Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report)’s share price was down 10.6% during mid-day trading on Thursday . The stock traded as low as $1.04 and last traded at $1.56. Approximately 821 shares traded hands during trading, a decline of 75% from the average daily volume of 3,341 shares. The stock had previously closed at $1.74.
Talis Biomedical Stock Performance
The stock’s 50 day simple moving average is $1.67 and its 200 day simple moving average is $1.73. The firm has a market cap of $2.83 million, a PE ratio of -0.06 and a beta of 1.47.
About Talis Biomedical
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Recommended Stories
- Five stocks we like better than Talis Biomedical
- Golden Cross Stocks: Pattern, Examples and Charts
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Investing in Commodities: What Are They? How to Invest in Them
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Roth IRA Calculator: Calculate Your Potential Returns
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
